ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
NCT06787144
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
CML (Chronic Myelogenous Leukemia)
Chronic Phase CML
Interventions
DRUG:
ELVN-001
Sponsor
Enliven Therapeutics